Hans Verbaan (Former)
21 – 30 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
High levels of serum antibodies to cell surface proteins of Helicobacter pullorum and Helicobacter pylori in hepatitis C virus-infected patients.
(
- Contribution to journal › Article
- 2008
-
Mark
Is sustained virological response to HCV treatment associated with a clinical important improvement in vitality?
2008) 43rd Annual Meeting of the European Association for the Study of the Liver In Journal of Hepatology 48(Suppl. 2). p.272-272(
- Contribution to journal › Published meeting abstract
-
Mark
Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
(
- Contribution to journal › Article
-
Mark
IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION AND RVR 14 WEEKS TREATMENT IS NON-INFERIOR TO 24 WEEKS. POOLED ANALYSIS OF TWO SCANDINAVIAN TRIALS
2008) 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases In Hepatology 48(4). p.1875-1875(
- Contribution to journal › Published meeting abstract
-
Mark
Prevalence of hepatitis C in Swedish diabetics is low and comparable to that in health care workers.
(
- Contribution to journal › Article
-
Mark
Prospective study of nosocomial transmission of hepatitis C in a Swedish gastroenterology unit .
(
- Contribution to journal › Article
- 2005
-
Mark
Partial splenic embolization as pretreatment for antiviral therapy in hepatitis C virus infection
(
- Contribution to journal › Article
-
Mark
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: A randomized, placebo-controlled study
(
- Contribution to journal › Article
- 2002
-
Mark
High sustained response rate in patients with histologically mild (low grade and stage) chronic hepatitis C infection. A randomized, double blind, placebo controlled trial of interferon alpha-2b with and without ribavirin.
(
- Contribution to journal › Article
- 2001
-
Mark
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease
(
- Contribution to journal › Article